Tech choice crucial in UK diabetes screening review
This article was originally published in Clinica
Executive Summary
By the end of this year, the UK National Screening Committee should have decided whether or not to screen for type 2 diabetes - but the implications of detecting a potentially significant number of cases of lesser glucose intolerance could have a major bearing on the NSC's choice of diagnostic technology.